Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I'm over in the pharma services side, and while we haven't had outright cancellations, there's definitely been a noticeable slowdown in approvals for new initiatives. Feels like a tighter budget leash, for sure. My manager is similar – vague answers about 'strategic realignments.' It's unsettling when you're used to a certain pace. Keep an eye on internal communications, maybe even reach out to HR for a general clarification on the company's current direction if it gets worse.
Diagnostic imaging here too, and I'm not feeling it as much. My team's roadmap is pretty solid, and we just got the green light on a new product launch. Maybe it's specific to your division or location? Could be project-specific delays or a reorganization that hasn't trickled down to everyone yet. Don't jump to conclusions based on hallway chatter; wait for official announcements. Things change, especially in large companies.